Literature DB >> 1820474

Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration.

F Facchini1, Y D Chen, C B Hollenbeck, G M Reaven.   

Abstract

OBJECTIVE: To define the relationship, if any, between insulin-mediated glucose disposal and serum uric acid.
DESIGN: Cross-sectional study of healthy volunteers.
SETTING: General Clinical Research Center, Stanford (Calif) University Medical Center. PARTICIPANTS: Thirty-six presumably healthy individuals, nondiabetic, without a history of gout. MEASUREMENTS: Obesity (overall and regional), plasma glucose and insulin responses to a 75-g oral glucose load, fasting uric acid concentrations, plasma triglyceride and high-density lipoprotein-cholesterol concentrations, systolic and diastolic blood pressure, insulin-mediated glucose disposal, and urinary uric acid clearance.
RESULTS: Magnitude of insulin resistance and serum uric acid concentration were significantly related (r = .69; P less than .001), and the relationship persisted when differences in age, sex, overall obesity, and abdominal obesity were taken into account (r = .57; P less than .001). Insulin resistance was also inversely related to urinary uric acid clearance (r = -.49; P less than .002), and, in addition, urinary uric acid clearance was inversely related to serum uric acid concentration (r = -.61; P less than .001).
CONCLUSIONS: Urinary uric acid clearance appears to decrease in proportion to increases in insulin resistance in normal volunteers, leading to an increase in serum uric acid concentration. Thus, it appears that modulation of serum uric concentration by insulin resistance is exerted at the level of the kidney.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1820474

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  190 in total

1.  Absence of an association between serum uric acid and mortality from cardiovascular disease: NIPPON DATA 80, 1980-1994. National Integrated Projects for Prospective Observation of Non-communicable Diseases and its Trend in the Aged.

Authors:  K Sakata; T Hashimoto; H Ueshima; A Okayama
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

Review 2.  Serum uric acid is not an independent risk factor for coronary heart disease.

Authors:  S G Wannamethee
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

3.  Serum uric acid levels and the risk of type 2 diabetes: a prospective study.

Authors:  Vidula Bhole; Jee Woong J Choi; Sung Woo Kim; Mary de Vera; Hyon Choi
Journal:  Am J Med       Date:  2010-10       Impact factor: 4.965

4.  Effect of serum insulin on the association between hyperuricemia and incident heart failure.

Authors:  Ravi V Desai; Mustafa I Ahmed; Gregg C Fonarow; Gerasimos S Filippatos; Michel White; Inmaculada B Aban; Wilbert S Aronow; Ali Ahmed
Journal:  Am J Cardiol       Date:  2010-10-15       Impact factor: 2.778

Review 5.  The insulin resistance syndrome.

Authors:  Gerald M Reaven
Journal:  Curr Atheroscler Rep       Date:  2003-09       Impact factor: 5.113

6.  Theory is acid test for fructose's blood pressure role.

Authors:  Roxanne Khamsi
Journal:  Nat Med       Date:  2010-09       Impact factor: 53.440

7.  Gender and age impacts on the correlations between hyperuricemia and metabolic syndrome in Chinese.

Authors:  Qing Zhang; Shanshan Lou; Zhaowei Meng; Xiaojun Ren
Journal:  Clin Rheumatol       Date:  2010-12-22       Impact factor: 2.980

Review 8.  Hyperuricemia and cardiovascular risk.

Authors:  Davide Grassi; Giovambattista Desideri; Anna Vittoria Di Giacomantonio; Paolo Di Giosia; Claudio Ferri
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-02-20

Review 9.  Cardiac allograft vasculopathy and insulin resistance--hope for new therapeutic targets.

Authors:  Luciano Potena; Hannah A Valantine
Journal:  Endocrinol Metab Clin North Am       Date:  2007-12       Impact factor: 4.741

Review 10.  Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal?

Authors:  Zohreh Soltani; Kashaf Rasheed; Daniel R Kapusta; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2013-06       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.